AKCEA THERAPEUTICS, INC. FORM OF PREFERRED STOCK WARRANT AGREEMENTPreferred Stock Warrant Agreement • September 18th, 2018 • Akcea Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 18th, 2018 Company Industry JurisdictionTHIS PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [•], between AKCEA THERAPEUTICS, INC., a Delaware corporation (the “Company”) and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).
AKCEA THERAPEUTICS, INC. AND , AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OFCommon Stock Warrant Agreement • September 18th, 2018 • Akcea Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 18th, 2018 Company Industry JurisdictionThis Common Stock Warrant Agreement (this “Agreement”), dated as of [•], between AKCEA THERAPEUTICS, INC., a Delaware corporation (the “Company”) and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).
AKCEA THERAPEUTICS, INC. FORM OF DEBT SECURITIES WARRANT AGREEMENTDebt Securities Warrant Agreement • September 18th, 2018 • Akcea Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 18th, 2018 Company Industry JurisdictionTHIS DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of [•], between AKCEA THERAPEUTICS, INC., a Delaware corporation (the “Company”) and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).
Akcea Therapeutics, Inc.,Indenture • September 18th, 2018 • Akcea Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 18th, 2018 Company Industry JurisdictionIndenture, dated as of [·], 20__, among Akcea Therapeutics, Inc., a Delaware corporation (the “Company”), and [Trustee], as trustee (the “Trustee”):